3.4.19.3	2-oxoimidazolidinyl-4-carbonyl-Gly-Ile + H2O	-	Bos taurus	?	-	?	74094	
3.4.19.3	4(R)-N-(2-nitroxyethyl)-2-oxothiazolidine-4-carboxamide + H2O	-	Mus musculus	L-2-oxothiazolidine-4-carboxylic acid + ?	-	?	383872	
3.4.19.3	4(R)-N-(2-nitroxyethyl)-2-oxothiazolidine-4-carboxamide + H2O	-	Homo sapiens	L-2-oxothiazolidine-4-carboxylic acid + ?	-	?	383872	
3.4.19.3	4(R)-N-(2-nitroxyethyl)-2-oxothiazolidine-4-carboxamide + H2O	-	Rattus norvegicus	L-2-oxothiazolidine-4-carboxylic acid + ?	-	?	383872	
3.4.19.3	5-pyrrolidone-2-carboxyl-His-Gly + H2O	slight activity	Cavia porcellus	?	-	?	74096	
3.4.19.3	5-pyrrolidone-2-carboxyl-His-Trp + H2O	-	Cavia porcellus	?	-	?	74095	
3.4.19.3	ACE inhibitor + H2O	contains the N-terminal dipeptide pyroglutamyl-Trp-	Homo sapiens	pyroglutamate + ?	-	?	365093	
3.4.19.3	acid-thyroliberin + H2O	-	Cavia porcellus	pyroglutamate + His-Pro	-	?	74088	
3.4.19.3	acid-thyroliberin + H2O	i.e. pyroglutamyl-His-Pro	Cavia porcellus	pyroglutamate + His-Pro	-	?	74088	
3.4.19.3	bombesin + H2O	-	Bos taurus	pyroglutamate + Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2	-	?	74099